Trimmed it because it moved up 145% the past year. They have a great franchise in cancer detection recurrence. Likes it long-term.
Stock price when the opinion was issued
A biotech that does, among other things, cancer testing which is very accurate.. She just bought it. Is growing fast and expects it to be cash-flow positive this year.
Build your watch list
Sign in to track investmentsyou care about
First Avenue Investment Counsel
CNBC
J. Zechner & Assoc
Stockchase Premium
Stockchase
Trimmed it because it moved up 145% the past year. They have a great franchise in cancer detection recurrence. Likes it long-term.